Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Aurobindo Pharma

Rahul Shah bullish on pharma, sees Sun Pharma and Aurobindo as key large-cap plays

Indian equity markets show a mixed but improving consumption trend, with selective FMCG and premium retail outperforming. Page Industries is highlighted as a strong recovery story, while Nykaa and Honasa are viewed cautiously. The pharma sector continues its outperformance, with Sun Pharma and Aurobindo Pharma looking attractive.

The Economic Times

Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?

Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business improvements, better margins, and strong earnings, the pharma major's market cap surged. Analysts see further upside but advise caution with stop losses due to the steep rise.

The Economic Times

Quant Mid Cap Fund exits Lenskart Solutions and 2 other stocks, adds SAIL in April

Quant Mid Cap Fund exited Lenskart Solutions, NMDC and SBI Cards in April, while adding Steel Authority of India to its portfolio, the fund’s monthly disclosure showed. The fund also increased exposure to Reliance Industries and maintained holdings in several key stocks, as sector allocations shifted toward healthcare and metals.

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

India’s electoral bonds laundry: ‘Corrupt’ firms paid parties, got cleansed

From PM Modi’s BJP to the opposition Trinamool Congress, parties gained from donations that activists say were dubious.

Al Jazeera

The legal issues surrounding Arvind Kejriwal’s arrest | Explained

Arvind Kejriwal arrest: The Hindu explores the legal issues surrounding the arrest of Delhi CM Arvind Kejriwal by the ED, including what legal contentions have been raised during the proceedings and what do judicial precedents say?

The Hindu

Pradhan Mantri Hafta Vasuli Yojana | Congress' swipe at government over electoral bonds issue

Congress general secretary Jairam Ramesh accused the Modi government of “hafta vasuli” (extortion) and claimed that 21 firms facing investigations from the CBI, Enforcement Directorate or I-T have donated through electoral bonds.

The Hindu

Aurobindo unit gets USFDA nod to market generic asthma medication

Aurobindo Pharma's subsidiary receives USFDA approval for generic asthma medication for children. Product expected to launch in FY25 with estimated market size of $226.4M. Shares up 1.51% on BSE.

The Hindu

Read news from The Economist, FT, and more,
with one subscription

Pharma sector continues to create more jobs, says Aurobindo Pharma senior vice-president

Aurobindo Pharma Ltd. senior V-P U.N.B. Raju said Indian pharma sector will create more jobs and spur economic activity. He was handing out certificates to 30 students who completed a four-month training in pharma quality control.

The Hindu

Delhi liquor scam: CBI records Telangana CM KCR's daughter K Kavita's statement in Hyderabad

HYDERABAD: Central Bureau of Investigation (CBI) has recorded the statements of Telangana chief minister K Chandrashekar Rao's daughter Kalvakuntla Kavita in the Delhi Excise police scam on Sunday after questioning for seven hours.

The Times of India

Andhra Pradesh: Aurobindo Pharma conducts skill training for youth in Srikakulam

A four-month session was conducted by the firm and Ambedkar University

The Hindu

Aurobindo acquires domestic formulations business of group company Veritaz for Rs 171 crore

HYDERABAD: As part of its strategy to foray into the Indian formulations market, Hyderabad-based pharma major Aurobindo Pharma is acquiring the domestic formulations business of another Hyderabad-based company Veritaz Healthcare, which is promoted by its promoters, on a slump sale basis for a consideration of Rs 171 crore on a…

The Times of India

Aurobindo gets licence for supply of Pfizer’s Covid pill

HYDERABAD: Pharma major Aurobindo Pharma Limited has inked a sub-license agreement with the United Nations-backed public health organisation Medicines Patent Pool (MPP) for manufacturing and supplying a generic version of Pfizer’s oral Covid-19 treatment drug nirmatrelvir to 95 countries, including India.

People

Abhishek Manu Singhvi

Magunta Srinivasulu Reddy

12 stories

Peyush Bansal

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

United Nations

37,495 stories

Bharatiya Janata Party

Enforcement Directorate

Central Bureau of Investigation

135 stories

PMLA

79 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.